Clincosm LogoSign in Get a demo

Myelodysplastic Syndrome (MDS)

Showing NaN - NaN of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelodysplastic Syndrome (MDS) Trial in Worldwide (Venetoclax, Azacitidine, Placebo)

Active, not recruiting
  • Myelodysplastic Syndrome (MDS)
  • Fullerton, California
  • +219 more
Aug 24, 2022

Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS) Trial in Worldwide (S64315 once a week, S64315 twice a week)

Completed
  • Acute Myeloid Leukaemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • S64315 once a week
  • S64315 twice a week
  • New Haven, Connecticut
  • +8 more
May 17, 2022

Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®

Active, not recruiting
  • Hematological Malignancies
  • +6 more
  • NiCord® (omidubicel)
  • Cord Blood Unit
  • Los Angeles, California
  • +51 more
Jan 7, 2021

Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS) Trial in Australia, France (S 055746)

Completed
  • Acute Myeloid Leukaemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • S 055746
  • Melbourne, Australia
  • +4 more
May 22, 2019

Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) Trial in France, Germany (drug, procedure, other, genetic)

Terminated
  • Myelodysplastic Syndrome (MDS)
  • Acute Myeloid Leukemia (AML)
  • Nantes, France
  • +9 more
Oct 23, 2018

Myelodysplastic Syndrome (MDS) Trial in Worldwide (Thymoglobulin®, Rabbit Anti-thymocyte Globulin (rATG))

Terminated
Has Results
  • Myelodysplastic Syndrome (MDS)
  • Thymoglobulin®, Rabbit Anti-thymocyte Globulin (rATG)
  • Paris, France
  • +6 more
Mar 17, 2015

Acute Myelogenous Leukaemia (AML), Myelodysplastic Syndrome (MDS) Trial in Paris (5 azacytidine - VALPROIC acid- Retinoic acid)

Completed
  • Acute Myelogenous Leukaemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • 5 azacytidine - VALPROIC acid- Retinoic acid
  • Paris, France
    Chu Saint Louis
May 6, 2011